The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Circulating tumour cells: their utility in cancer management and predicting outcomes
Open accessAbstract
Recent advances in technology now permit robust and reproducible detection of circulating tumour cells (CTCs) from a simple blood test. Standardization in methodology has been instrumental in facilitating multicentre trials with the purpose of evaluating the clinical utility of CTCs. We review the current body of evidence supporting the prognostic value of CTC enumeration in breast, prostate and colorectal cancer, using standardized approaches, and studies evaluating the correlation of CTC number with radiological outcome. The exploitation of CTCs in cancer management, however, is now extending beyond prognostication. As technologies emerge to characterize CTCs at the molecular level, biological information can be obtained in real time, with the promise of serving as a ‘surrogate tumour biopsy’. Current studies illuminate the potential of CTCs as pharmacodynamic and predictive biomarkers and potentially their use in revealing drug resistance in real time. Approaches for CTC characterization are summarized and the potential of CTCs in cancer patient management exemplified via the detection of epidermal growth factor receptor mutations from CTCs in patients with non-small cell lung cancer. The opportunity to learn more about the biology of metastasis through CTC analysis is now being realized with the horizon of CTC-guided development of novel anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 1×
“The entire process of metastasis appears to be inefficient in that only the ‘decathlon champions’ of CTCs (as coined by Isaiah Fidler [Fidler, 2003]) are successful in establishing distant metastatic disease.”
BackgroundCirculating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2622 · Cited by 2,649
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 4×
“The presence varied widely in samples from different carcinomas with frequency being highest in metastatic prostate, unknown primary, ovary and breast carcinomas [Allard et al. 2004].”
BackgroundMethodInfluentialde Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Epithelial–mesenchymal transitions in development and pathologies
Thiery, J. P. (2003) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2003.10.006 · Cited by 1,704
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
Hayes, D. F., Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Miller, M. C., Matera, J., Allard, W. J., Doyle, G. V., & Terstappen, L. W. W. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2821 · Cited by 1,030
(1970) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/45.4.773 · Cited by 1,025
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Krebs, M. G., Sloane, R., Priest, L., Lancashire, L., Hou, J.-M., Greystoke, A., Ward, T. H., Ferraldeschi, R., Hughes, A., Clack, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.7045 · Cited by 868
Self-citationA case of cancer in which cells similar to those in the tumours were seen in the blood after death
Ashworth, T. G. (1869) · Medical Entomology and Zoology · Cited by 842
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
Budd, G. T., Cristofanilli, M., Ellis, M. J., Stopeck, A., Borden, E., Miller, M. C., Matera, J., Repollet, M., Doyle, G. V., Terstappen, L. W. M. M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1769 · Cited by 775
Miller, M. C., Doyle, G. V., & Terstappen, L. W. M. M. (2010) · Journal of Oncology · doi:10.1155/2010/617421 · Cited by 750
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2333 · Cited by 736
Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer
Danila, D. C., Heller, G., Gignac, G. A., Gonzalez-Espinoza, R., Anand, A., Tanaka, E., Lilja, H., Schwartz, L., Larson, S., Fleisher, M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1506 · Cited by 665
Pantel, K., Alix-Panabières, C., & Riethdorf, S. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.44 · Cited by 643
Sequist, L. V., Bell, D. W., Lynch, T. J., & Haber, D. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.3585 · Cited by 624
Scher, H. I., Jia, X., de Bono, J. S., Fleisher, M., Pienta, K. J., Raghavan, D., & Heller, G. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70340-1 · Cited by 611
The significance of hematogenous tumor cell clumps in the metastatic process.
Liotta, L. A., Saidel, M. G., & Kleinerman, J. I. (1976) · PubMed · Cited by 567
Attard, G., Swennenhuis, J. F., Olmos, D., Reid, A. H. M., Vickers, E., A'Hern, R., Levink, R., Coumans, F., Moreira, J., Riisnaes, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3667 · Cited by 533 · cited 2×
“…in CTCs including amplification of androgen receptor (AR) and MYC [Leversha et al. 2009]; gene copy number for chromosomes 1, 7, 8 and 17 [Swennenhuis et al. 2009]; and fusions of TMPRSS2-ERG together with AR and phosphatase and tensin homologue (PTEN) amplifications [Attard et al. 2009].”
BackgroundPrognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M. A., Mitchell, E., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
HER-2 gene amplification can be acquired as breast cancer progresses
Meng, S., Tripathy, D., Shete, S., Ashfaq, R., Haley, B., Perkins, S., Beitsch, P., Khan, A., Euhus, D., Osborne, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402993101 · Cited by 508
Epithelial-Mesenchymal Transition and Cell Cooperativity in Metastasis
Tsuji, T., Ibaragi, S., & Hu, G.-F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1618 · Cited by 413
Mechanisms of collective cell migration at a glance
Ilina, O., & Friedl, P. (2009) · Journal of Cell Science · doi:10.1242/jcs.036525 · Cited by 381
Global Gene Expression Profiling of Circulating Tumor Cells
Smirnov, D. A., Zweitzig, D. R., Foulk, B. W., Miller, M. C., Doyle, G. V., Pienta, K. J., Meropol, N. J., Weiner, L. M., Cohen, S. J., Moreno, J. G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4330 · Cited by 329
Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer
Liu, M. C., Shields, P. G., Warren, R. D., Cohen, P., Wilkinson, M., Ottaviano, Y. L., Rao, S. B., Eng-Wong, J., Seillier-Moiseiwitsch, F., Noone, A.-M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.6664 · Cited by 319
The “seed and soil” hypothesis revisited
Fidler, I. J., & Poste, G. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70201-8 · Cited by 314
Exploring a New Twist on Tumor Metastasis
Yang, J., Mani, S. A., & Weinberg, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3850 · Cited by 297
Theodoropoulos, P. A., Polioudaki, H., Agelaki, S., Kallergi, G., Saridaki, Z., Mavroudis, D., & Georgoulias, V. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.06.027 · Cited by 284
Cancer Invasion and Metastasis
Wittekind, C., & Neid, M. (2005) · Oncology · doi:10.1159/000086626 · Cited by 269
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Alunni-Fabbroni, M., & Sandri, M. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.027 · Cited by 250
Olmos, D., Arkenau, H.-T., Ang, J. E., Ledaki, I., Attard, G., Carden, C. P., Reid, A. H. M., A'Hern, R., Fong, P. C., Oomen, N. B., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn544 · Cited by 243
Hou, J.-M., Greystoke, A., Lancashire, L., Cummings, J., Ward, T., Board, R., Amir, E., Hughes, S., Krebs, M., Hughes, A., et al. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090078 · Cited by 238
Self-citationTol, J., Koopman, M., Miller, M. C., Tibbe, A., Cats, A., Creemers, G. J. M., Vos, A. H., Nagtegaal, I. D., Terstappen, L. W. M. M., & Punt, C. J. A. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp463 · Cited by 216
Statistical considerations for enumeration of circulating tumor cells
Tibbe, A. G. J., Miller, M. C., & Terstappen, L. W. M. M. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20369 · Cited by 215
Pestrin, M., Bessi, S., Galardi, F., Truglia, M., Biggeri, A., Biagioni, C., Cappadona, S., Biganzoli, L., Giannini, A., & Di Leo, A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0461-7 · Cited by 201
Allan, A. L., & Keeney, M. (2010) · Journal of Oncology · doi:10.1155/2010/426218 · Cited by 196
Fehm, T., Becker, S., Duerr-Stoerzer, S., Sotlar, K., Mueller, V., Wallwiener, D., Lane, N., Solomayer, E., & Uhr, J. (2007) · Breast Cancer Research · doi:10.1186/bcr1783 · Cited by 196
de Bono, J. S., Attard, G., Adjei, A., Pollak, M. N., Fong, P. C., Haluska, P., Roberts, L., Melvin, C., Repollet, M., Chianese, D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0268 · Cited by 192
The CTC-Chip: An Exciting New Tool to Detect Circulating Tumor Cells in Lung Cancer Patients
Sequist, L. V., Nagrath, S., Toner, M., Haber, D. A., & Lynch, T. J. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181989565 · Cited by 189
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Leversha, M. A., Han, J., Asgari, Z., Danila, D. C., Lin, O., Gonzalez-Espinoza, R., Anand, A., Lilja, H., Heller, G., Fleisher, M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2036 · Cited by 188
Metastasis of cancer: a conceptual history from antiquity to the 1990s.
Weiss, L. (2000) · PubMed · Cited by 169
Desar, I. M. E., van Herpen, C. M. L., van Laarhoven, H. W. M., Barentsz, J. O., Oyen, W. J. G., & van der Graaf, W. T. A. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.12.001 · Cited by 160
Nolé, F., Munzone, E., Zorzino, L., Minchella, I., Salvatici, M., Botteri, E., Medici, M., Verri, E., Adamoli, L., Rotmensz, N., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm558 · Cited by 159
Hayes, D., Walker, T., Singh, B., Vitetta, E., Uhr, J., Gross, S., Rao, C., Doyle, G., & Terstappen, L. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.5.1111 · Cited by 158
Moreno, J. G., O'Hara, S. M., Gross, S., Doyle, G. V., Fritsche, H. A., Gomella, L. G., & Terstappen, L. W. M. M. (2001) · Urology · doi:10.1016/s0090-4295(01)01191-8 · Cited by 154
Giorgi, U. D., Valero, V., ROHREN, E. M., Dawood, S. S., Ueno, N. T., Miller, M. C., Doyle, G. V., Jackson, S. A., Andreopoulou, E., Handy, B. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.4423 · Cited by 136
Nakamura, S., Yagata, H., Ohno, S., Yamaguchi, H., Iwata, H., Tsunoda, N., Ito, Y., Tokudome, N., Toi, M., Kuroi, K., et al. (2009) · Breast Cancer · doi:10.1007/s12282-009-0139-3 · Cited by 124
Characterization of circulating tumor cells by fluorescence in situ hybridization
Swennenhuis, J. F., Tibbe, A. G. J., Levink, R., Sipkema, R., & Terstappen, L. W. M. M. (2009) · Cytometry Part A · doi:10.1002/cyto.a.20718 · Cited by 122
Observations on the Antiquity of Cancer and Metastasis
Weiss, L. (2000) · Cancer and Metastasis Reviews · doi:10.1023/a:1010646304844 · Cited by 116
Coman, D. R., Delong, R. P., & McCutcheon, M. (1951) · PubMed · Cited by 105
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
Mandrekar, S. J., Qi, Y., Hillman, S. L., Ziegler, K. L. A., Reuter, N. F., Rowland, K. M., Kuross, S. A., Marks, R. S., Schild, S. E., & Adjei, A. A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c0a313 · Cited by 38
Circulating tumor cells in metastatic breast cancer: timing of blood extraction for analysis.
Martín, M., García-Sáenz, J. Á., Casas, M. L. M. D. L., Vidaurreta, M., Puente, J., Veganzones, S., Lajusticia, L. R., de la Orden, V., Oliva, B., de la Torre, J., et al. (2009) · PubMed · Cited by 20
Cited by
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Self-citationRudin, C. M., Hann, C. L., Garon, E. B., Ribeiro de Oliveira, M., Bonomi, P. D., Camidge, D. R., Chu, Q., Giaccone, G., Khaira, D., Ramalingam, S. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3090 · Cited by 564
Self-citationKrebs, M. G., Hou, J.-M., Sloane, R., Lancashire, L., Priest, L., Nonaka, D., Ward, T. H., Backen, A., Clack, G., Hughes, A., et al. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31823c5c16 · Cited by 463
Self-citationCirculating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Hou, J.-M., Krebs, M., Ward, T., Sloane, R., Priest, L., Hughes, A., Clack, G., Ranson, M., Blackhall, F., & Dive, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.003 · Cited by 426
Self-citation
Metadata
- Authors
- Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H., & Dive, C.
- Venue
- Therapeutic Advances in Medical Oncology
- Publisher
- SAGE Publications
- Published
- 2010-08-16
- Volume
- 2
- Issue
- 6
- Pages
- 351-365
- ISSN
- 1758-8340 (ISSN-L)
- 1758-8359
- OpenAlex
- W2092406850
- Cited by
- 259
- References
- 64
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.